S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:ATHX

Athersys (ATHX) Stock Price, News & Analysis

$0.0056
0.00 (0.00%)
(As of 03/26/2024 ET)
Today's Range
$0.0056
$0.0066
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$1.99
Volume
18,706 shs
Average Volume
1.77 million shs
Market Capitalization
$345,626.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ATHX stock logo

About Athersys Stock (NASDAQ:ATHX)

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.

ATHX Stock Price History

ATHX Stock News Headlines

StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)
Toughbuilt Industries Inc (TBLT)
Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $300 on Your Annual Subscription
Athersys Inc ATHXQ
Athersys to Sell Most Assets to Healios
Athersys shares delisted by Nasdaq Stock Market
4x Better than Bitcoin
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Athersys crashes after bankruptcy warning
Athersys Director Jane Wasman Appointed Board Chair
Is Athersys Inc (ATHX) Significantly Overvalued?
Why Is Athersys (ATHX) Stock Down 36% Today?
Athersys (NASDAQ: ATHX)
See More Headlines
Receive ATHX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athersys and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
3/28/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATHX
Employees
24
Year Founded
1995

Profitability

Net Income
$-72,530,000.00
Pretax Margin
-46,304.93%

Debt

Sales & Book Value

Annual Sales
$146,000.00
Book Value
($1.33) per share

Miscellaneous

Free Float
61,700,000
Market Cap
$345,626.40
Optionable
Optionable
Beta
-0.90

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Daniel A. Camardo M.B.A. (Age 54)
    CEO, Secretary & Director
    Comp: $796.81k
  • Ms. Z. Kasey Rosado (Age 49)
    Interim Chief Financial Officer
    Comp: $1.51M
  • Ms. Maia A. Hansen M.B.A. (Age 54)
    M.S., Chief Operating Officer
    Comp: $962.57k
  • Senthil Ranganathan Ph.D.
    Vice President of Technical Operations
  • Mr. David Russ M.B.A.
    Vice President of Supply Chain, Finance & Administration
  • Dr. Manal Morsy M.B.A.
    M.D., PH.D., Executive VP & Head of Global Regulatory Affairs
  • Dr. Robert Mays Ph.D.
    Executive VP, Head of Regenerative Medicine & Neuroscience Programs
  • Mr. Rakesh Ramachandran MS
    Head of Information Technology & Communications and VP
  • Dr. Sarah Busch Ph.D.
    VP of Regenerative Medicine & Head of Business Development
  • Ms. Ellen Gurley
    Manager of Corporate Communications and Investor Relations

ATHX Stock Analysis - Frequently Asked Questions

How have ATHX shares performed in 2024?

Athersys' stock was trading at $0.02 at the beginning of 2024. Since then, ATHX stock has decreased by 72.0% and is now trading at $0.0056.
View the best growth stocks for 2024 here
.

When is Athersys' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our ATHX earnings forecast
.

How were Athersys' earnings last quarter?

Athersys, Inc. (NASDAQ:ATHX) issued its earnings results on Monday, November, 15th. The biopharmaceutical company reported ($1.75) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.00) by $0.25. The biopharmaceutical company had revenue of $4.79 million for the quarter. During the same period in the prior year, the business earned ($2.75) EPS.

When did Athersys' stock split?

Shares of Athersys reverse split before market open on Monday, August 29th 2022. The 1-25 reverse split was announced on Monday, August 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What is William (B.J.) Lehmann's approval rating as Athersys' CEO?

1 employees have rated Athersys Chief Executive Officer William (B.J.) Lehmann on Glassdoor.com. William (B.J.) Lehmann has an approval rating of 100% among the company's employees. This puts William (B.J.) Lehmann in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 65.0% of employees surveyed would recommend working at Athersys to a friend.

What other stocks do shareholders of Athersys own?
Who are Athersys' major shareholders?

Athersys' stock is owned by a number of retail and institutional investors. Top institutional investors include Citadel Advisors LLC (0.00%), Concourse Financial Group Securities Inc. (0.00%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Daniel A Camardo, Ismail Kola, Ivor Macleod, John J Harrington, John J Harrington and William Lehmann Jr.
View institutional ownership trends
.

How do I buy shares of Athersys?

Shares of ATHX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATHX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners